Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444763
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-24
Brief Title:
Effect of Maolactin FMR on Exercise Recovery Inflammation and Muscle Comfort in an Otherwise Healthy Population
Sponsor:
RDC Clinical Pty Ltd
Organization:
RDC Clinical Pty Ltd
Study Overview
Official Title:
Effect of Maolactin FMR Supplementation on Exercise Recovery Inflammation and Muscle Comfort in an Otherwise Healthy Population a Double-blind Randomized Placebo-controlled Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a double blind randomised placebo-controlled parallel-group trial to evaluate the effect of Maolactin FMR supplementation on chronic inflammation mobility and muscle and joint pain in an otherwise healthy population of adults 45-65 years old over 14 weeks with 12 weeks supplementation
This is PART B of the study
This is PART B of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None